Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 229 (6%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3283 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-OLMESARTAN/HCTZ | 12.5MG 40MG | TABLET | Resolved | 2017-07-25 | 2018-04-23 | 16905 |
| APO-OLMESARTAN/HCTZ | 25MG 40MG | TABLET | Resolved | 2018-01-17 | 2018-04-23 | 36321 |
| APO-OLMESARTAN/HCTZ | 25MG 40MG | TABLET | Resolved | 2018-07-04 | 2020-07-11 | 54300 |
| APO-OLMESARTAN/HCTZ | 12.5MG 20MG | TABLET | Resolved | 2018-07-04 | 2018-11-22 | 54303 |
| APO-OLMESARTAN/HCTZ | 12.5MG 40MG | TABLET | Resolved | 2018-12-12 | 2020-07-11 | 69452 |
| APO-OLMESARTAN/HCTZ | 12.5MG 20MG | TABLET | Resolved | 2018-12-27 | 2020-07-11 | 70532 |
| APO-OLMESARTAN/HCTZ | 25MG 40MG | TABLET | Actual shortage | 2024-01-19 | 2024-11-14 | 216717 |
| APO-OLMESARTAN/HCTZ | 12.5MG 20MG | TABLET | Actual shortage | 2024-01-19 | 2024-09-16 | 216720 |
| APO-OLMESARTAN/HCTZ | 12.5MG 40MG | TABLET | Actual shortage | 2024-01-19 | 2024-11-14 | 216723 |
| APO-OLOPATADINE | 0.2% | SOLUTION | Resolved | 2017-05-30 | 2017-06-30 | 11567 |
| APO-OLOPATADINE | 0.2% | SOLUTION | Resolved | 2018-05-31 | 2018-10-12 | 50964 |
| APO-OLOPATADINE | 0.1% | SOLUTION | Resolved | 2019-04-18 | 2019-06-24 | 82016 |
| APO-OLOPATADINE | 0.2% | SOLUTION | Resolved | 2019-07-31 | 2019-08-02 | 90347 |
| APO-OLOPATADINE | 0.2% | SOLUTION | Resolved | 2019-11-20 | 2021-09-01 | 99317 |
| APO-OLOPATADINE | 0.1% | SOLUTION | Actual shortage | 2020-06-04 | 2020-06-04 | 116551 |
| APO-OLOPATADINE | 0.2% | SOLUTION | Actual shortage | 2024-03-27 | 2024-03-27 | 223564 |
| APO-OMEPRAZOLE | 20MG | CAPSULE (DELAYED RELEASE) | Resolved | 2017-03-10 | 2017-04-04 | 408 |
| APO-OMEPRAZOLE | 20MG | CAPSULE (DELAYED RELEASE) | Resolved | 2017-03-12 | 2017-04-04 | 674 |
| APO-OMEPRAZOLE | 20MG | CAPSULE (DELAYED RELEASE) | Resolved | 2019-09-25 | 2019-10-28 | 94744 |
| APO-OMEPRAZOLE | 20MG | CAPSULE (DELAYED RELEASE) | Resolved | 2020-09-17 | 2020-09-28 | 124353 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
| APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
| APO-HYDROMORPHONE CR | 30MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110971 |
| APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110974 |
| APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |
| APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
| APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |